176 related articles for article (PubMed ID: 33065129)
1. Efficient LRP1-Mediated Uptake and Low Cytotoxicity of Peptide L57 In Vitro Shows Its Promise as CNS Drug Delivery Vector.
Rodrigues JP; Prajapati N; DeCoster MA; Poh S; Murray TA
J Pharm Sci; 2021 Feb; 110(2):824-832. PubMed ID: 33065129
[TBL] [Abstract][Full Text] [Related]
2. A novel LRP1-binding peptide L57 that crosses the blood brain barrier.
Sakamoto K; Shinohara T; Adachi Y; Asami T; Ohtaki T
Biochem Biophys Rep; 2017 Dec; 12():135-139. PubMed ID: 29090274
[TBL] [Abstract][Full Text] [Related]
3. Generation of KS-487 as a novel LRP1-binding cyclic peptide with higher affinity, higher stability and BBB permeability.
Sakamoto K
Biochem Biophys Rep; 2022 Dec; 32():101367. PubMed ID: 36237444
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2.
Demeule M; Currie JC; Bertrand Y; Ché C; Nguyen T; Régina A; Gabathuler R; Castaigne JP; Béliveau R
J Neurochem; 2008 Aug; 106(4):1534-44. PubMed ID: 18489712
[TBL] [Abstract][Full Text] [Related]
5. Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery.
Wei X; Zhan C; Chen X; Hou J; Xie C; Lu W
Mol Pharm; 2014 Oct; 11(10):3261-8. PubMed ID: 24673510
[TBL] [Abstract][Full Text] [Related]
6. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.
Zhou X; Smith QR; Liu X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1695. PubMed ID: 33470550
[TBL] [Abstract][Full Text] [Related]
7. LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases.
Guo Q; Zhu Q; Miao T; Tao J; Ju X; Sun Z; Li H; Xu G; Chen H; Han L
J Control Release; 2019 Jun; 303():117-129. PubMed ID: 31026546
[TBL] [Abstract][Full Text] [Related]
8. Transport characteristics of a novel peptide platform for CNS therapeutics.
Bertrand Y; Currie JC; Demeule M; Régina A; Ché C; Abulrob A; Fatehi D; Sartelet H; Gabathuler R; Castaigne JP; Stanimirovic D; Béliveau R
J Cell Mol Med; 2010 Dec; 14(12):2827-39. PubMed ID: 19818094
[TBL] [Abstract][Full Text] [Related]
9. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
[TBL] [Abstract][Full Text] [Related]
10. In vitro discrimination of the role of LRP1 at the BBB cellular level: focus on brain capillary endothelial cells and brain pericytes.
Candela P; Saint-Pol J; Kuntz M; Boucau MC; Lamartiniere Y; Gosselet F; Fenart L
Brain Res; 2015 Jan; 1594():15-26. PubMed ID: 25451130
[TBL] [Abstract][Full Text] [Related]
11. Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood-brain barrier in vitro and in vivo.
Kafa H; Wang JT; Rubio N; Klippstein R; Costa PM; Hassan HA; Sosabowski JK; Bansal SS; Preston JE; Abbott NJ; Al-Jamal KT
J Control Release; 2016 Mar; 225():217-29. PubMed ID: 26809004
[TBL] [Abstract][Full Text] [Related]
12. Human induced pluripotent stem cells (BIONi010-C) generate tight cell monolayers with blood-brain barrier traits and functional expression of large neutral amino acid transporter 1 (SLC7A5).
Goldeman C; Andersen M; Al-Robai A; Buchholtz T; Svane N; Ozgür B; Holst B; Shusta E; Hall VJ; Saaby L; Hyttel P; Brodin B
Eur J Pharm Sci; 2021 Jan; 156():105577. PubMed ID: 33011235
[TBL] [Abstract][Full Text] [Related]
13. Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment.
Khan NU; Ni J; Ju X; Miao T; Chen H; Han L
Acta Pharm Sin B; 2021 May; 11(5):1341-1354. PubMed ID: 34094838
[TBL] [Abstract][Full Text] [Related]
14. The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells.
Yamada K; Hashimoto T; Yabuki C; Nagae Y; Tachikawa M; Strickland DK; Liu Q; Bu G; Basak JM; Holtzman DM; Ohtsuki S; Terasaki T; Iwatsubo T
J Biol Chem; 2008 Dec; 283(50):34554-62. PubMed ID: 18940800
[TBL] [Abstract][Full Text] [Related]
15. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
[TBL] [Abstract][Full Text] [Related]
16. Signature Effects of Vector-Guided Systemic Nano Bioconjugate Delivery Across Blood-Brain Barrier of Normal, Alzheimer's, and Tumor Mouse Models.
Israel LL; Galstyan A; Cox A; Shatalova ES; Sun T; Rashid MH; Grodzinski Z; Chiechi A; Fuchs DT; Patil R; Koronyo-Hamaoui M; Black KL; Ljubimova JY; Holler E
ACS Nano; 2022 Aug; 16(8):11815-11832. PubMed ID: 35961653
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport.
Guo YX; He LY; Zhang M; Wang F; Liu F; Peng WX
Neuroscience; 2016 May; 322():28-38. PubMed ID: 26820600
[TBL] [Abstract][Full Text] [Related]
18. Influence of the Drug Position on Bioactivity in Angiopep-2-Daunomycin Conjugates.
Pethő L; Oláh-Szabó R; Mező G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834514
[TBL] [Abstract][Full Text] [Related]
19. Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors.
Kristensen M; Brodin B
J Pharm Sci; 2017 Sep; 106(9):2326-2334. PubMed ID: 28501469
[TBL] [Abstract][Full Text] [Related]
20. Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1.
Bertrand Y; Currie JC; Poirier J; Demeule M; Abulrob A; Fatehi D; Stanimirovic D; Sartelet H; Castaigne JP; Béliveau R
Br J Cancer; 2011 Nov; 105(11):1697-707. PubMed ID: 22027709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
